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Abstract 
Tobacco smoking is a known cause of gastric cancer, but several aspects of the association 
remain imprecisely quantified. We examined the relation between cigarette smoking and 
gastric cancer risk using a uniquely large dataset of 23 epidemiological studies within the 
“Stomach cancer Pooling (StoP) Project”, including 10,290 cases and 26,145 controls. We 
estimated summary odds-ratios (ORs) and the corresponding 95% confidence intervals (CIs) 
by pooling study-specific ORs using random-effects models. Compared to never smokers, the 
ORs were 1.20 (95% CI 1.09-1.32) for ever, 1.12 (95% CI 0.99-1.27) for former and 1.25 
(95% CI 1.11-1.40) for current cigarette smokers. Among current smokers, the risk increased 
with number of cigarettes per day to reach an OR of 1.32 (95% CI 1.10-1.58) for smokers of 
more than 20 cigarettes per day. The risk increased with duration of smoking, to reach an OR 
of 1.33 (95% CI 1.14-1.54) for more than 40 years of smoking, and decreased with increasing 
time since stopping cigarette smoking (p for trend<0.01) and became similar to that of never 
smokers 10 years after stopping. Risks were somewhat higher for cardia than non-cardia 
gastric cancer. Risks were similar when considering only studies with information on 
Helicobacter pylori (HP) infection, and comparing all cases to HP+ controls only. This study 
provides the most precise estimate of the detrimental effect of cigarette smoking on gastric 
cancer risk based on individual data, including the relationship with dose and duration, and 
the decrease in risk following stopping smoking. 
 
Keywords: Consortia, Epidemiology, Pooled analysis, Tobacco smoking, Stomach neoplasms 
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Introduction 
Tobacco smoking has been causally linked to gastric cancer (IARC Working Group, 
2012). Two meta-analyses of published literature considering, respectively, 32 cohort 
(Ladeiras-Lopes et al., 2008) and 46 case-control studies (La Torre et al., 2009) showed a 
significant increase in risk of gastric cancer among smokers, though quantification of dose-
response relations remains imprecise.  
Risk of gastric cancer was reported to increase with increasing dose and duration of 
cigarette smoking in some studies (Gonzalez et al., 2003; Ladeiras-Lopes et al., 2008; 
Tramacere et al., 2011; Nomura et al., 2012). Furthermore, some studies showed a stronger 
association between cigarette smoking and gastric cardia rather than non-cardia cancer 
(Gonzalez et al., 2003; Freedman et al., 2007; Nomura et al., 2012), but others did not 
confirm this finding (Lindblad et al., 2005; Steevens et al., 2010).  
Lower risks have been generally found in former compared to current smokers, and the 
risk seems to decrease with increasing years since stopping smoking, although such 
relationship was not significant in several studies (Gonzalez et al., 2003; Koizumi et al., 
2004; Freedman et al., 2007; Kim et al., 2007; Zendehdel et al., 2008; IARC Working Group, 
2012). 
To better define and quantify the association between cigarette smoking and gastric 
cancer, we conducted an individual participant data meta-analysis of studies participating to 
the “Stomach cancer Pooling (StoP) Project”, a recently established consortium of 
epidemiological studies on risk factors for gastric cancer.  
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Methods 
This analysis is based on data from 23 case-control studies included in the first release 
of the “StoP Project” dataset, including 10,290 cases (6804 men, 3486 women) and 26,145 
controls (15,600 men, 10,545 women) from Greece (Lagiou et al., 2004), Italy (4 studies) 
(Buiatti et al., 1989; La Vecchia et al., 1995; Lucenteforte et al., 2008; De Feo et al., 2012), 
Portugal (Lunet et al., 2007), Russia (Zaridze et al., 2000), Spain (2 studies) (Santibanez et 
al., 2012; Castano-Vinyals et al., 2015), Sweden (3 studies, 2 of which were nested in cohort 
studies) (Ye et al., 1999; Harris et al., 2013), China (4 studies) (Setiawan et al., 2000; Mu et 
al., 2005; Setiawan et al., 2005; Deandrea et al., 2010), Iran (3 studies) (Derakhshan et al., 
2008; Pourfarzi et al., 2009; Pakseresht et al., 2011), Japan (Matsuo et al., 2013), Canada 
(Mao et al., 2002), and USA (2 studies) (Zhang et al., 1999). Detailed information on the 
aims and methods of the “StoP Project” has been given elsewhere (Pelucchi et al., 2015). 
The principal investigators of participating studies were asked to provide information 
about cigarette smoking status (never, former, and current smoker), number of cigarettes 
smoked per day, duration of smoking, and time since stopping smoking, when applicable. 
Data were harmonized according to a pre-specified format and completeness and consistency 
between variables were carefully checked. For the present analysis, ever cigarette smokers 
were defined as participants who had smoked at least 100 cigarettes in their lifetime or more 
than one cigarette per day for at least 1 year, independently of the type of cigarette smoked 
(e.g., cigarettes with or without filter, with blond or black tobacco, hand-rolled cigarettes, 
etc.). Smoked forms of tobacco other than cigarettes, i.e. cigar and pipes, were considered in 
a separate category. Two studies (Setiawan et al., 2000; Derakhshan et al., 2008) providing 
information on lifetime cigarette status (ever, never) only were not considered in the dose-risk 
analyses on intensity and duration. We also collected information on a list of additional 
variables to be introduced as confounders and to define subgroups. 
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For two cohort studies included in the StoP Project consortium, the Swedish 
Mammography Cohort and the Cohort of Swedish Men (Harris et al., 2013), a nested case-
control design was used by selecting 4 controls for each case, matched on age. 
To estimate the association between cigarette smoking and gastric cancer, we used a 
two-stage modeling approach (Smith-Warner et al., 2006). In the first stage, we assessed the 
association between cigarette smoking and gastric cancer for each study by estimating the 
odds ratios (ORs) and the corresponding 95% CIs using multivariable unconditional logistic 
regression models (for categorical variables). These models included, when available and 
appropriate, terms for age (<40, 40-44, 45-49, 50–54, 55–59, 60–64, 65–69, 70–74, ≥75 
years), sex, education/social class (study-specific low, intermediate, high), race/ethnicity 
(White, Hispanic/Latino, Black/African American, other), alcohol drinking (never, low ≤12 
gr/day, intermediate >12-≤47 gr/day, high >47 gr/day), fruit and vegetables consumption 
(study-specific tertiles) and study center (for multicentric studies).  The list of study-specific 
confounders is reported in Supplementary Table 1. 
In the second stage, summary (pooled) effects estimates were computed using a 
random-effect model, by computing a weighted average of the study-specific log(ORs) 
obtained in the first stage, using as weights the inverse of the sum of the study-specific 
log(ORs) variances and the between-study variance components (DerSimonian and Laird, 
1986). 
For categorical variables, heterogeneity between studies was evaluated using the Q test 
statistics and quantified using I2, i.e. the proportion of total variation contributed by between-
study variance (Higgins et al., 2003). 
To investigate whether the effect of smoking was heterogeneous across strata of 
selected covariates, we conducted analyses stratified by age (<55, >55-<65, >65), sex, 
9 
 
geographic area (Europe, Asia, America), cancer site (cardia, non cardia), cancer histotype 
(intestinal, diffuse, undifferentiated) and type of controls (hospital controls, population 
controls; controls from 2 nested case-control studies were considered together with the latter).  
We also evaluated the influence of H.pylori infection on the relation between cigarette 
smoking and gastric cancer. We considered only studies with the information on H.pylori 
infection and compared the pooled ORs obtained using all controls with that obtained using 
only H.pylori positive controls (assuming all gastric cancer cases are positive for H.pylori 
infection.  
We tested for the significance of linear trends across levels of smoking intensity and 
duration variables by estimating study-specific trends and using the Wald test P value 
deriving from the summary random-effects estimate (Smith-Warner et al., 2006).  
For continuous variables, we studied the functional form of the relation using one-
order and two-order fractional polynomial models. The method was based on a two-stage 
procedure. In a first step, we fitted first-order and second-order fractional polynomial models 
to each study adjusting for the aforementioned confounders. This family of models includes 
the linear one. In the second step, the pooled dose-risk relation was estimated through a 
bivariate random effects model (Rota et al., 2010). The best fitting model, i.e. the one 
minimizing the model deviance, was selected when the best fitting model was non linear 
(Royston et al., 1999).  
 
Results 
Table 1 shows the distribution of cases and controls by study, sex, age and major selected 
potential confounding factors, for a descriptive purpose only. Cases were older than controls 
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(mean age ± SD: 63 ± 11 vs. 60 ± 13, respectively) and had a lower social class. Overall, 
8.6% of cases reported a history of stomach cancer in first degree relatives and 11.2% 
reported consumption of 4 or more drinks/day of alcoholic beverages (i.e., >47 grams/day of 
ethanol). 
Figure 1 gives a forest plot of the study-specific and the pooled ORs for gastric cancer 
risk on the basis of all 23 studies participating to the consortium. The pooled estimate was 
1.20 (95% CI 1.09-1.32) for ever smokers compared to never smokers. 
The pooled ORs of gastric cancer according to cigarette smoking habits are given in 
Table 2. Among 21 studies reporting information on former smoking status, the pooled ORs 
were 1.19 (95% CI 1.09-1.31) for ever cigarette smokers, 1.12 (95% CI 0.99-1.27) for former 
cigarette smokers and 1.25 (95% CI 1.11-1.40) for current smokers, compared with never 
smokers. Among current smokers, the risk increased with number of cigarettes smoked per 
day. Compared to never smokers, ORs were 1.08 (95% CI 0.91-1.28) for 1 to 10 cigarettes 
per day, 1.30 (95% CI 1.16-1.45) for 11 to 20 cigarettes per day and 1.32 (95% CI 1.10-1.58) 
for more than 20 cigarettes per day, with a significant trend in risk (p<0.01). The risk also 
increased with increasing duration of smoking (p-value for trend<0.01) with ORs of 1.04 
(95% CI 0.94-1.16) for up to 30 years of smoking, 1.32 (95% CI 1.17-1.49) for 31 to 40 years 
of smoking and 1.33 (95% CI 1.14-1.54) for more than 40 years of smoking, as compared to 
never smokers. A significant decreasing trend in risk was found with increasing time since 
stopping cigarette smoking (p<0.01), taking current smokers as reference group. 
Study-specific and pooled ORs of gastric cancer for former and current smokers 
according to cigarette smoking intensity are shown in Figure 2. Heterogeneity between 
studies was low to moderate (I2 between 19% and 56%) across categories of consumption. 
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Figure 3 gives the modeled relation between smoking intensity (Panel A) and duration 
(Panel B) considered as continuous variables and gastric cancer risk. For both variables, the 
best fitting model was the one with powers p1=-2 and p2=2, i.e. log(OR)= β1 X-2 + β2 X2. The 
estimated regression coefficients were β1= -0.00002 and β2= 0.000023 for smoking intensity, 
β1= -1.46E-06 and β2= 0.000136  for duration. Overall, duration appeared to have a somewhat 
stronger effect on risk than intensity. These graphs suggest that the intensity- and duration-
risk relationships have a strong non-linear component (p<0.001).  
Stratified analyses according to smoking intensity are given in Figure 4 and 
Supplementary Table 2. The ORs for high intensity of cigarette smoking (i.e., >20 cigarettes 
per day) were similar in men (OR=1.44, 95% CI 1.00-2.08) and women (OR=1.42, 95% CI 
1.18-1.72), and higher in subjects aged 56-65 years (OR=1.64, 95% CI 1.33-2.03) and in 
studies conducted in Asia (OR=1.71, 95% CI 1.08-2.71) than in the other groups. However, 
none of these differences was statistically significant. Risks of gastric cardia cancer were 
somewhat higher than those of non-cardia gastric cancer in former (ORs=1.30 and 1.05, 
respectively), light (ORs=1.71 and 0.96, respectively) and moderate cigarette smokers 
(ORs=1.55 and 1.21, respectively). For subjects reporting high intensity of cigarette smoking, 
the ORs were 1.58 for cardia (95% CI 1.11-2.24) and 1.29 for non-cardia (95% CI 1.03-1.61) 
gastric cancer, and when looking at histotype, 1.28 (95% CI 0.90-1.81) for diffuse-type and 
1.57 (95% CI 1.12-2.20) for intestinal-type gastric cancer. Effects of cigarette smoking on 
gastric cancer risk did not materially change when considering only studies with information 
on H.pylori infection (>20 cigarettes per day, OR=1.40, 95% CI 0.91-2.15) even when the 
analysis was restricted to H.pylori positive controls (>20 cigarettes per day, OR=1.48, 95% CI 
0.93-2.36). Risks for smoking appeared to be somewhat higher in studies with hospital 
controls (>20 cigarettes per day, OR=1.58, 95% CI 1.33-1.87) than in those with population 
controls (>20 cigarettes per day, OR=1.18, 95% CI 0.87-1.60).  
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Stratified analyses on smoking duration according to sex, age, geographic area, cancer 
site, cancer histotype, source of controls and H.pylori infection are given in Supplementary 
Table 3. When considering long-term smokers (i.e., >40 years of smoking), risks appeared to 
be higher in gastric cardia (OR=1.78, 95% CI 1.44-2.19) than in non-cardia (OR=1.19, 95% 
CI 0.97-1.46) cancer cases, and in studies with hospital controls (OR=1.64, 95% CI 1.29-
2.10) than in those with population controls (OR=1.17, 95% CI 0.98-1.38). 
 
Discussion 
This global dataset confirms the association between cigarette smoking and gastric cancer 
risk. This is the largest individual participant analysis on stomach neoplasms, including 
comprehensive and uniform information on relevant covariates, and thus provides the most 
precise and valid estimates of several quantitative aspects of the association.  A 25% excess 
risk of gastric cancer was found among current smokers. The risk significantly increased with 
cigarette smoking intensity and duration, to reach 32% for smokers of more than 20 cigarettes 
per day and 33% for smoking duration of more than 40 years, as compared to never smokers. 
The increase in risk was steeper for duration than for dose. The risk declined with time since 
stopping smoking and approached the level of never cigarette smokers about 10 years after 
quitting.   
These results are generally consistent with previous meta-analyses. Our OR estimates for 
current cigarette smokers were, if anything, slightly lower than those based on published 
studies, which found risks ranging between 1.5 and 1.7 (Tredaniel et al., 1997; Ladeiras-
Lopes et al., 2008; La Torre et al., 2009; Bonequi et al., 2013), resulting in an estimated 
worldwide population attributable fraction of 19.5% in men and 3.0% in women (Peleteiro et 
al., 2015). Publication bias may have led to an over estimation of the risk in the published 
literature. In fact, only about one-third of the studies included in this pooled-analysis were 
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present in previous meta-analyses of case-control (La Torre et al., 2009) or cohort studies 
(Ladeiras-Lopes et al., 2008).   
Concerning the dose-risk relation for intensity and duration, previous results are limited. 
A meta-analysis of cohort studies (Ladeiras-Lopes et al., 2008) showed an increasing trend in 
risk with smoking intensity, with a relative risk (RR) varying from 1.3 for the lowest dose, to 
1.7 for 30 cigarettes per day. A significant trend in gastric cancer risk with increasing duration 
was reported in the European Investigation into Cancer and Nutrition (EPIC) (Gonzalez et al., 
2003) and in the Multiethnic Cohort (MEC) study (Nomura et al., 2012). Although the 
association of gastric cancer with smoking has been long recognized, this study confirms that 
the risk is modest even at high doses, in spite of the increasing dose-risk gradient. Although 
the association with cigarette smoking is weaker for gastric cancer than for lung cancer, our 
pooled analysis finds a stronger relation with duration than with dose, as it has been shown 
for lung cancer. 
An interesting finding of our study is the lower gastric cancer risk for former smokers as 
compared to current smokers, in particular >10 years after stopping. This has been suggested 
by previous studies (Gonzalez et al., 2003; Ladeiras-Lopes et al., 2008; Nomura et al., 2012) 
and adds stomach cancer to the list of diseases whose risk is favorably affected by stopping 
smoking. 
This pooled analysis reported similar findings in men and women. With reference to the 
site of cancer, two large cohort studies reported a higher risk of gastric cardia than non-cardia 
cancer in current smokers (Gonzalez et al., 2003; Nomura et al., 2012). A recent meta-
analysis including 10 studies on gastric cardia adenocarcinoma reported an over two-fold risk 
for smokers of more than 40 years compared to never smokers (Tramacere et al., 2011). A 
differential role of smoking (besides H.pylori (Kamangar et al., 2006)) in the aetiology of 
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different gastric cancer subsites has also been hypothesized to contribute to the diverging 
trends in risk of gastric cardia and non-cardia cancers over the last decades (Gonzalez et al., 
2003). In this investigation, though the ORs for high intensity cigarette smokers were not 
statistically heterogeneous between subsites (i.e., 1.40 for gastric cardia and 1.29 for gastric 
non-cardia cancer), the risk tended to be higher for gastric cardia and patterns tended to differ. 
In fact, gastric cardia cancer risk was increased and higher than that for non-cardia subsite in 
light to moderate smokers, in long-term smokers, and among former smokers. Thus, the dose-
risk and time-risk relations might be different between gastric cardia and non-cardia cancer, 
suggesting underlying differences in biological mechanisms involved.  
Many mechanisms may explain the effect of tobacco smoking on gastric cancer 
occurrence. Several carcinogens contained in tobacco products, including N-nitroso 
compounds, have been involved in the etiology of gastric cancer (Mirvish, 1995). In vitro, a 
carcinogenic effect of tobacco smoke on the gastric mucosa has been reported (Tayler and 
Piper, 1977). In a population-based gastroscopic screening study, smoking has also been 
significantly associated with the development of precursor lesion of gastric cancer, i.e. 
dysplasia, chronic atrophic gastritis and intestinal metaplasia, (Kneller et al., 1992). In gastric 
cancer cases, levels of stable DNA adducts were significantly higher in the DNA of smokers 
than in that of non smokers (Dyke et al., 1992). Some studies investigated gene interaction 
with tobacco smoking in gastric cancerogenesis. Polymorphisms of GSTT1, SULT1A1, 
CYP1a1 and NAT2 genes appear to be implicated in modulating individual’s susceptibility 
between smoking and gastric cancer (Agudo et al., 2006; Lee et al., 2006; Boccia et al., 
2007). Furthermore the hypermethylation of CDH1 gene was observed preferentially in 
gastric tumors from smokers rather than non-smokers (Poplawski et al., 2008). 
Among the strengths of the study, the “StoP Project” included original and individual data 
on smoking on over 10,000 cases and 26,000 controls, which provided a unique opportunity 
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to investigate and accurately quantify the dose- and time factors- risk relationships and, 
among former smokers, the pattern of risk with time since stopping. The individual level 
approach has several advantages as compared to study-level meta-analyses, specifically the 
availability of detailed and uniform information on important covariates (Ioannidis et al., 
2013). For instance, we were able to investigate the confounding effect of H.pylori infection 
by restricting the analysis to controls positive for H.pylori infection (all cases were supposed 
to be H.pylori infected). This sensitivity analysis confirmed the results of the main analysis, 
thus providing further evidence of a role of cigarette smoking independent from that of 
H.pylori. Confounding from other specific factors, such as consumption of salted and smoked 
foods, cannot entirely be ruled out. Also, we found a substantial heterogeneity between 
studies that was not explained by age, sex and geographic area. Among potential explanations 
for the reported heterogeneity is that the type of cigarettes commonly smoked (e.g., with or 
without filter, with blond or black tobacco, hand-rolled, etc.) varies in different countries, 
together with their variable tar and nicotine concentrations. We were not able to address the 
role of such factors, however, since only a minority of studies had available information on 
type of cigarette smoked. The association was, if anything, stronger in studies using hospital 
controls. This is reassuring since it has been suggested that smokers may be over represented 
among hospital controls given the higher hospitalization rates and longer hospital stays in 
smokers compared to non smokers. 
In conclusion, this investigation confirms a detrimental, although modest, effect of 
cigarette smoking on gastric cancer risk, provides the most valid and precise estimates of 
dose-risk and duration-risk relations, and clearly shows a decrease in risk after stopping 
smoking, which is important for primary prevention. 
 
Acknowledgments 
16 
 
The authors thank the European Cancer Prevention (ECP) Organization for providing support 
for the project meetings. 
  
17 
 
References 
Agudo A, Sala N, Pera G, Capella G, Berenguer A, Garcia N, et al. (2006). Polymorphisms in 
metabolic genes related to tobacco smoke and the risk of gastric cancer in the 
European prospective investigation into cancer and nutrition. Cancer Epidemiol 
Biomarkers Prev  15: 2427-2434. 
Boccia S, Sayed-Tabatabaei FA, Persiani R, Gianfagna F, Rausei S, Arzani D, et al. (2007). 
Polymorphisms in metabolic genes, their combination and interaction with tobacco 
smoke and alcohol consumption and risk of gastric cancer: a case-control study in an 
Italian population. BMC Cancer  7: 206. 
Bonequi P, Meneses-Gonzalez F, Correa P, Rabkin CS, Camargo MC (2013). Risk factors for 
gastric cancer in Latin America: a meta-analysis. Cancer Causes Control  24: 217-
231. 
Buiatti E, Palli D, Decarli A, Amadori D, Avellini C, Bianchi S, et al. (1989). A case-control 
study of gastric cancer and diet in Italy. Int J Cancer  44: 611-616. 
Castano-Vinyals G, Aragones N, Perez-Gomez B, Martin V, Llorca J, Moreno V, et al. 
(2015). Population-based multicase-control study in common tumors in Spain (MCC-
Spain): rationale and study design. Gac Sanit  29: 308-315. 
De Feo E, Simone B, Persiani R, Cananzi F, Biondi A, Arzani D, et al. (2012). A case-control 
study on the effect of Apolipoprotein E genotypes on gastric cancer risk and 
progression. BMC Cancer  12: 494. 
Deandrea S, Foschi R, Galeone C, La Vecchia C, Negri E, Hu J (2010). Is temperature an 
effect modifier of the association between green tea intake and gastric cancer risk? Eur 
J Cancer Prev  19: 18-22. 
18 
 
Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, et al. (2008). 
Combination of gastric atrophy, reflux symptoms and histological subtype indicates 
two distinct aetiologies of gastric cardia cancer. Gut  57: 298-305. 
DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials  7: 177-
188. 
Dyke GW, Craven JL, Hall R, Garner RC (1992). Smoking-related DNA adducts in human 
gastric cancers. Int J Cancer  52: 847-850. 
Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR, et al. (2007). 
A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer 
subtypes. Am J Epidemiol  165: 1424-1433. 
Gonzalez CA, Pera G, Agudo A, Palli D, Krogh V, Vineis P, et al. (2003). Smoking and the 
risk of gastric cancer in the European Prospective Investigation Into Cancer and 
Nutrition (EPIC). Int J Cancer  107: 629-634. 
Harris H, Håkansson N, Olofsson C, Julin B, Åkesson A, Wolk A (2013). The Swedish 
Mammography Cohort and the Cohort of Swedish Men: Study design and 
characteristics of 2 population-based longitudinal cohorts. OA Epidemiology  1: 16. 
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-
analyses. BMJ  327: 557-560. 
IARC Working Group (2012). Tobacco smoking. In: IARC Monographs on the Evaluation of 
Carcinogenic Risks to Humans, vol. 100E: Personal Habits and indoor combustion. 
International Agency for Reseach on Cancer: Lyon: 43-211. 
Ioannidis JP, Schully SD, Lam TK, Khoury MJ (2013). Knowledge integration in cancer: 
current landscape and future prospects. Cancer Epidemiol Biomarkers Prev  22: 3-10. 
19 
 
Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, et al. 
(2006). Opposing risks of gastric cardia and noncardia gastric adenocarcinomas 
associated with Helicobacter pylori seropositivity. J Natl Cancer Inst  98: 1445-1452. 
Kim Y, Shin A, Gwack J, Jun JK, Park SK, Kang D, et al. (2007). [Cigarette smoking and 
gastric cancer risk in a community-based cohort study in Korea]. J Prev Med Public 
Health  40: 467-474. 
Kneller RW, You WC, Chang YS, Liu WD, Zhang L, Zhao L, et al. (1992). Cigarette 
smoking and other risk factors for progression of precancerous stomach lesions. J Natl 
Cancer Inst  84: 1261-1266. 
Koizumi Y, Tsubono Y, Nakaya N, Kuriyama S, Shibuya D, Matsuoka H, et al. (2004). 
Cigarette smoking and the risk of gastric cancer: a pooled analysis of two prospective 
studies in Japan. Int J Cancer  112: 1049-1055. 
La Torre G, Chiaradia G, Gianfagna F, De Lauretis A, Boccia S, Mannocci A, et al. (2009). 
Smoking status and gastric cancer risk: an updated meta-analysis of case-control 
studies published in the past ten years. Tumori  95: 13-22. 
La Vecchia C, D'Avanzo B, Negri E, Decarli A, Benichou J (1995). Attributable risks for 
stomach cancer in northern Italy. Int J Cancer  60: 748-752. 
Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, et 
al. (2008). Smoking and gastric cancer: systematic review and meta-analysis of cohort 
studies. Cancer Causes Control  19: 689-701. 
Lagiou P, Samoli E, Lagiou A, Peterson J, Tzonou A, Dwyer J, et al. (2004). Flavonoids, 
vitamin C and adenocarcinoma of the stomach. Cancer Causes Control  15: 67-72. 
Lee K, Caceres D, Varela N, Csendes DA, Rios RH, Quinones SL (2006). [Allelic variants of 
cytochrome P4501A1 (CYP1A1), glutathione S transferase M1 (GSTM1) 
20 
 
polymorphisms and their association with smoking and alcohol consumption as gastric 
cancer susceptibility biomarkers]. Rev Med Chil  134: 1107-1115. 
Lindblad M, Rodriguez LA, Lagergren J (2005). Body mass, tobacco and alcohol and risk of 
esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and 
women in a nested case-control study. Cancer Causes Control  16: 285-294. 
Lucenteforte E, Scita V, Bosetti C, Bertuccio P, Negri E, La Vecchia C (2008). Food groups 
and alcoholic beverages and the risk of stomach cancer: a case-control study in Italy. 
Nutr Cancer  60: 577-584. 
Lunet N, Valbuena C, Vieira AL, Lopes C, David L, Carneiro F, et al. (2007). Fruit and 
vegetable consumption and gastric cancer by location and histological type: case-
control and meta-analysis. Eur J Cancer Prev  16: 312-327. 
Mao Y, Hu J, Semenciw R, White K (2002). Active and passive smoking and the risk of 
stomach cancer, by subsite, in Canada. Eur J Cancer Prev  11: 27-38. 
Matsuo K, Oze I, Hosono S, Ito H, Watanabe M, Ishioka K, et al. (2013). The aldehyde 
dehydrogenase 2 (ALDH2) Glu504Lys polymorphism interacts with alcohol drinking 
in the risk of stomach cancer. Carcinogenesis  34: 1510-1515. 
Mirvish SS (1995). Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of 
gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of 
known exposures to NOC. Cancer Lett  93: 17-48. 
Mu LN, Lu QY, Yu SZ, Jiang QW, Cao W, You NC, et al. (2005). Green tea drinking and 
multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer  
116: 972-983. 
Nomura AM, Wilkens LR, Henderson BE, Epplein M, Kolonel LN (2012). The association of 
cigarette smoking with gastric cancer: the multiethnic cohort study. Cancer Causes 
Control  23: 51-58. 
21 
 
Pakseresht M, Forman D, Malekzadeh R, Yazdanbod A, West RM, Greenwood DC, et al. 
(2011). Dietary habits and gastric cancer risk in north-west Iran. Cancer Causes 
Control  22: 725-736. 
Peleteiro B, Castro C, Morais S, Ferro A, Lunet N (2015). Worldwide Burden of Gastric 
Cancer Attributable to Tobacco Smoking in 2012 and Predictions for 2020. Dig Dis 
Sci  60: 2470-2476. 
Pelucchi C, Lunet N, Boccia S, Zhang ZF, Praud D, Boffetta P, et al. (2015). The stomach 
cancer pooling (StoP) project: study design and presentation. Eur J Cancer Prev  24: 
16-23. 
Poplawski T, Tomaszewska K, Galicki M, Morawiec Z, Blasiak J (2008). Promoter 
methylation of cancer-related genes in gastric carcinoma. Exp Oncol  30: 112-116. 
Pourfarzi F, Whelan A, Kaldor J, Malekzadeh R (2009). The role of diet and other 
environmental factors in the causation of gastric cancer in Iran--a population based 
study. Int J Cancer  125: 1953-1960. 
Rota M, Bellocco R, Scotti L, Tramacere I, Jenab M, Corrao G, et al. (2010). Random-effects 
meta-regression models for studying nonlinear dose-response relationship, with an 
application to alcohol and esophageal squamous cell carcinoma. Stat Med  29: 2679-
2687. 
Royston P, Ambler G, Sauerbrei W (1999). The use of fractional polynomials to model 
continuous risk variables in epidemiology. Int J Epidemiol  28: 964-974. 
Santibanez M, Alguacil J, de la Hera MG, Navarrete-Munoz EM, Llorca J, Aragones N, et al. 
(2012). Occupational exposures and risk of stomach cancer by histological type. 
Occup Environ Med  69: 268-275. 
22 
 
Setiawan VW, Zhang ZF, Yu GP, Li YL, Lu ML, Tsai CJ, et al. (2000). GSTT1 and GSTM1 
null genotypes and the risk of gastric cancer: a case-control study in a Chinese 
population. Cancer Epidemiol Biomarkers Prev  9: 73-80. 
Setiawan VW, Yu GP, Lu QY, Lu ML, Yu SZ, Mu L, et al. (2005). Allium vegetables and 
stomach cancer risk in China. Asian Pac J Cancer Prev  6: 387-395. 
Smith-Warner SA, Spiegelman D, Ritz J, Albanes D, Beeson WL, Bernstein L, et al. (2006). 
Methods for pooling results of epidemiologic studies: the Pooling Project of 
Prospective Studies of Diet and Cancer. Am J Epidemiol  163: 1053-1064. 
Steevens J, Schouten LJ, Goldbohm RA, van den Brandt PA (2010). Alcohol consumption, 
cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a 
prospective cohort study. Gut  59: 39-48. 
Tayler R, Piper DW (1977). The carcinogenic effect of cigarette smoke. The effect of 
cigarette smoke on human gastric mucosal cells in organ culture. Cancer  39: 2520-
2523. 
Tramacere I, La Vecchia C, Negri E (2011). Tobacco smoking and esophageal and gastric 
cardia adenocarcinoma: a meta-analysis. Epidemiology  22: 344-349. 
Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A (1997). Tobacco smoking and gastric 
cancer: review and meta-analysis. Int J Cancer  72: 565-573. 
Ye W, Ekstrom AM, Hansson LE, Bergstrom R, Nyren O (1999). Tobacco, alcohol and the 
risk of gastric cancer by sub-site and histologic type. Int J Cancer  83: 223-229. 
Zaridze D, Borisova E, Maximovitch D, Chkhikvadze V (2000). Alcohol consumption, 
smoking and risk of gastric cancer: case-control study from Moscow, Russia. Cancer 
Causes Control  11: 363-371. 
23 
 
Zendehdel K, Nyren O, Luo J, Dickman PW, Boffetta P, Englund A, et al. (2008). Risk of 
gastroesophageal cancer among smokers and users of Scandinavian moist snuff. Int J 
Cancer  122: 1095-1099. 
Zhang ZF, Kurtz RC, Klimstra DS, Yu GP, Sun M, Harlap S, et al. (1999). Helicobacter 
pylori infection on the risk of stomach cancer and chronic atrophic gastritis. Cancer 
Detect Prev  23: 357-367. 
  
24 
 
FIGURES LEGEND 
Figure 1. Study-specific and pooled ORs and corresponding 95% confidence intervals of 
gastric cancer risk for ever smokers compared to never smokers in the Stomach cancer 
Pooling (StoP) Project consortium. 
Figure 2. Study-specific and pooled ORs and corresponding 95% confidence intervals of 
gastric cancer risk for former smokers (a), smokers of up to 10 cigarettes (b), smokers of more 
than 10 to 20 cigarettes (c) and smokers of more than 20 cigarettes per day (d), compared to 
never smokers in the Stomach cancer Pooling (StoP) Project consortium. 
Figure 3. Relation between intensity (a), duration of cigarette smoking (b) and risk of gastric 
cancer according to the best fitting fractional polynomial model, i.e. the one with powers p1=-
2 and p2=2, in the Stomach cancer Pooling (StoP) Project consortium. 
Figure 4. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) for gastric cancer 
according to intensity of cigarette smoking in strata of sex, age, geographic area, cancer site, 
cancer histotype, Helicobacter Pylori infection and controls recruitment in the Stomach 
cancer Pooling (StoP) Project consortium. 
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Table 1. Distribution of 10,290 cases of gastric cancer and 26,145 controls according to study 
center, sex, age, and other selected covariates in the Stomach cancer Pooling (StoP) Project 
consortium. 
 Cases Controls N % N % 
Total 10290  26145  
Study center (Reference)     
Europe 5079 49.4 12664 48.4 
Greece (Lagiou et al., 2004) 110 1.1 100 0.4 
Italy 1 (La Vecchia et al., 1995) 769 7.5 2081 8.0 
Italy 2 (Lucenteforte et al., 2008) 230 2.2 547 2.1 
Italy 3 (De Feo et al., 2012) 160 1.6 444 1.7 
Italy 4 (Buiatti et al., 1989) 1016 9.9 1159 4.4 
Portugal (Lunet et al., 2007) 692 6.7 1667 6.4 
Russia (Zaridze et al., 2000) 450 4.4 611 2.3 
Spain 1 (Castano-Vinyals et al., 2015) 441 4.3 3440 13.2 
Spain 2 (Santibanez et al., 2012) 401 3.9 455 1.7 
Sweden 1 (Harris et al., 2013) 88 0.9 352 1.3 
Sweden 2 (Harris et al., 2013) 161 1.6 644 2.5 
Sweden 3 (Ye et al., 1999) 561 5.5 1164 4.5 
     
Asia 3197 31.1 6234 23.8 
China 1 (Deandrea et al., 2010) 266 2.6 533 2.0 
China 2 (Mu et al., 2005) 206 2.0 415 1.6 
China 3 (Setiawan et al., 2005) 711 6.9 711 2.7 
China 4 (Setiawan et al., 2000) 133 1.3 431 1.6 
Iran 1 (Pourfarzi et al., 2009) 217 2.1 394 1.5 
Iran 2 (Pakseresht et al., 2011) 286 2.8 304 1.2 
Iran 3 (Derakhshan et al., 2008) 118 1.1 119 0.5 
Japan (Matsuo et al., 2013) 1260 12.2 3327 12.7 
     
North America 2014 19.6 7247 27.7 
Canada (Mao et al., 2002) 1182 11.5 5033 19.3 
USA 1 (Zhang et al., 1999) 132 1.3 132 0.5 
USA 2 (unpublished data, J Muscat) 700 6.8 2082 8.0 
     
     
Sex     
Male 6804 66.1 15600 59.7 
Female 3486 33.9 10545 40.3 
     
Age     
<40 355 3.4 1917 7.3 
40-45 362 3.5 1542 5.9 
45-50 608 5.9 2009 7.7 
50-54 995 9.7 2700 10.3 
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55-59 1340 13.0 3128 12.0 
60-64 1616 15.7 4079 15.6 
65-69 1864 18.1 4240 16.2 
70-75 1864 18.1 3857 14.8 
≥75 1286 12.5 2673 10.2 
     
Social class1     
Low 5416 52.6 10625 40.6 
Intermediate 2697 26.2 7857 30.1 
High 1242 12.1 5422 20.7 
Missing 935 9.1 2241 8.6 
     
History of stomach cancer in first degree 
relatives2     
No 5139 49.9 13092 50.1 
Yes 885 8.6 1287 4.9 
Missing 4266 41.5 11766 45.0 
     
Vegetables and fruit intake3     
Low 3028 29.4 6812 26.1 
Intermediate 3107 30.2 7649 29.3 
High 2995 29.1 8224 31.5 
Missing 1160 11.3 3460 13.2 
     
Alcohol drinking (gr/day)4     
Never 2194 21.3 6231 23.8 
Low (≤12) 2089 20.3 7296 27.9 
Intermediate (>12 and ≤47) 2418 23.5 5429 20.8 
High (>47) 1155 11.2 2313 8.8 
Missing 2434 23.7 4876 18.6 
     
1No information available for study Iran 3 (Derakhshan et al., 2008). 
2No information available for studies China 1 (Deandrea et al., 2010), Canada (Mao et al., 2002), China 3 
(Setiawan et al., 2005), Iran 3 (Derakhshan et al., 2008), USA 2 (unpublished data, J Muscat), Sweden 1 
(Harris et al., 2013) and Sweden 2 (Harris et al., 2013). 
3No information available for studies USA 1 (Zhang et al., 1999), China 4 (Setiawan et al., 2000), Iran 3 
(Derakhshan et al., 2008). 
4Alcohol drinking was not available in category of consumption for the study Iran 2 (Pakseresht et al., 
2011), China 3 (Setiawan et al., 2005), Sweden 3 (Ye et al., 1999), China 4 (Setiawan et al., 2000), Iran 3 
(Derakhshan et al., 2008). 
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Table 2. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) for gastric cancer according 
to cigarette and tobacco smoking habits in the Stomach cancer Pooling (StoP) Project consortium. 
 Cases Controls OR (CI 95%)1 N % N % 
Total 10290  26145   
Cigarette smoking status      
Never smoker 4261 41.4 11742 44.9 1 
Ever cigarette smoker 5814 56.5 13910 53.2 1.20 (1.09-1.32) 
Other than cigarette smoker 122 1.2 343 1.3 1.07 (0.76-1.51) 
missing 93 0.9 150 0.6  
      
Total2 10039  25595   
Cigarette smoking status      
Never smoker 4122 41.1 11369 44.4 1 
Ever cigarette smoker 5510 54.9 13539 52.9 1.19 (1.09-1.31) 
Former cigarette smoker 2727 27.2 7361 28.8 1.12 (0.99-1.27) 
Current cigarette smoker 2783 27.7 6178 24.1 1.25 (1.11-1.40) 
Other than cigarette smoker 122 1.2 343 1.3 1.06 (0.76-1.48) 
missing 287 2.9 353 1.4  
      
Intensity (cigarettes per day)3      
0 to ≤10 673 6.7 1738 6.8 1.08 (0.91-1.28) 
>10 to ≤20 1310 13.0 2742 10.7 1.30 (1.16-1.45) 
> 20 (median value: 30) 767 7.6 1582 6.2 1.32 (1.10-1.58) 
missing 320 3.2 469 1.8  
P value for trend     0.0001 
      
Cigarette smoking duration (years)      
0 to ≤30 2210 22.0 6947 27.1 1.04 (0.94-1.16) 
>30 to ≤40 1420 14.1 3029 11.8 1.32 (1.17-1.49) 
> 40 (median value: 47) 1660 16.5 2999 11.7 1.33 (1.14-1.54) 
missing 507 5.1 917 3.6  
P value for trend     <0.0001 
      
Total4 7657  18222   
Time since stopping cigarette smoking (years)      
Never smoker 3204 41.8 8185 44.9 1 
0 to <10 656 8.6 1504 8.3 1.10 (0.92-1.31) 
10 to <20 515 6.7 1392 7.6 1.04 (0.90-1.19) 
≥ 20 (median value: 27) 615 8.0 1728 9.5 1.00 (0.84-1.19) 
Other than cigarette smoker 122 1.6 343 1.9  
Missing 248 3.2 453 2.5  
P value for trend     0.26 
      
Time since stopping cigarette smoking (years)      
Current cigarette smoker 2297 30.0 4616 25.3 1 
0 to <10 656 8.6 1504 8.3 0.87 (0.72-1.05) 
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10 to <20 515 6.7 1392 7.6 0.80 (0.70-0.92) 
≥ 20 (median value: 27) 615 8.0 1728 9.5 0.79 (0.63-0.99) 
Other than cigarette smoker 122 1.6 343 1.9  
Missing 248 3.2 453 2.5  
P value for trend     0.007 
1Pooled ORs were computed using random-effects models. Study-specific ORs were adjusted, when available, for sex, 
age, race/ethnicity, social class, alcohol drinking, fruit and vegetable consumption and study center for multicentric 
studies. 2Information on former/current smoking status was not available for studies China 4 (Setiawan et al., 2000) 
and Iran 3 (Derakhshan et al., 2008). 
3Current smokers only.  
4Time since stopping cigarette smoking was not available for studies Greece (Lagiou et al., 2004), Canada (Mao et al., 
2002), China 1 (Deandrea et al., 2010), Iran 1 (Pourfarzi et al., 2009), Iran 2 (Pakseresht et al., 2011), USA 1 (Zhang 
et al., 1999), Sweden 1 (Harris et al., 2013), and Sweden 2 (Harris et al., 2013). 
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